These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33257042)

  • 21. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants and risk of sudden sensorineural hearing loss: a population-based cohort study.
    Zhong PX; Li IH; Shih JH; Yeh CB; Chiang KW; Kao LT
    Int J Epidemiol; 2021 Nov; 50(5):1686-1697. PubMed ID: 33742212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
    Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety.
    Gibson-Smith D; Bot M; Milaneschi Y; Twisk JW; Visser M; Brouwer IA; Penninx BW
    J Clin Psychiatry; 2016 Feb; 77(2):e144-51. PubMed ID: 26760137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EEG microstates as markers of major depressive disorder and predictors of response to SSRIs therapy.
    Lei L; Liu Z; Zhang Y; Guo M; Liu P; Hu X; Yang C; Zhang A; Sun N; Wang Y; Zhang K
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110514. PubMed ID: 35085607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association Between Antidepressant Effect of SSRIs and Astrocytes: Conceptual Overview and Meta-analysis of the Literature.
    Chen B; Zhang M; Ji M; Gong W; Chen B; Zorec R; Stenovec M; Verkhratsky A; Li B
    Neurochem Res; 2021 Oct; 46(10):2731-2745. PubMed ID: 33527219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk for major depressive disorder in severely obese patients after bariatric surgery - a 12-year nationwide cohort study.
    Lu CW; Chang YK; Lee YH; Kuo CS; Chang HH; Huang CT; Hsu CC; Huang KC
    Ann Med; 2018 Nov; 50(7):605-612. PubMed ID: 30101619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder.
    Zhou ZY; Sun S; Chopra P; Zhong Y; Totev T; Signorovitch J
    J Med Econ; 2015; 18(11):919-29. PubMed ID: 26121061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Second-Generation Antidepressant Treatment on the Memory of Patients With Major Depressive Disorder: A Meta-analysis Study With Structural Equation Models.
    Gudayol-Ferré E; Duarte-Rosas P; Peró-Cebollero M; Guàrdia-Olmos J
    J Clin Psychopharmacol; 2020; 40(1):54-62. PubMed ID: 31834095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.
    Posternak MA; Zimmerman M
    J Clin Psychiatry; 2005 Jun; 66(6):705-7. PubMed ID: 15960562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between selective serotonin reuptake inhibitors and kidney cancer risk: A nationwide population-based cohort study.
    Lee MJ; Huang CW; Chen YL; Yang YH; Chen VC
    Int J Cancer; 2021 Mar; 148(6):1331-1337. PubMed ID: 32965039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.
    Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Abarca JE; Herrera-Guzmán D; Montelongo-Pedraza P; Padrós Blázquez F; Peró-Cebollero M; Guàrdia-Olmos J
    J Affect Disord; 2010 Jun; 123(1-3):341-50. PubMed ID: 19896719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bidirectional association between major depressive disorder and dementia: Two population-based cohort studies in Taiwan.
    Liu CC; Lin CY; Liu CH; Chang KC; Wang SK; Wang JY
    Compr Psychiatry; 2023 Nov; 127():152411. PubMed ID: 37722203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors related to the length of stay for major depressive disorder patients in China: A real-world retrospective study.
    Cheng P; Wang L; Xu L; Zhou Y; Zhao G; Zhang L; Li W
    Front Public Health; 2022; 10():892133. PubMed ID: 35968457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.